ClinicalTrialsFinder
RecruitingPhase 2NCT07489885

A Study to Evaluate D-2570 in Participants With Moderate to Severe Plaque Psoriasis

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase II Study to Evaluate the Efficacy and Safety of D-2570 in Participants With Moderate to Severe Plaque Psoriasis

Sponsor

InventisBio Co., Ltd

Enrollment

75 participants

Start Date

Jun 3, 2026

Study Type

INTERVENTIONAL

Conditions

Psoriasis

Summary

A Study looking at the safety and efficacy of D-2570 in Participants with Plaque Psoriasis

Eligibility

Min Age: 18 YearsMax Age: 70 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called D-2570 Tablet and a drug called Placebo Tablets for people with psoriasis. The study is currently recruiting participants at 2 locations. People eligible for this study include aged 18 Years to 70 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGD-2570 Tablet

Active Treatment

DRUGPlacebo Tablets

Identical Tablet

Locations(20)

Study Center

Birmingham, Alabama, United States

Study Center

Phoenix, Arizona, United States

Study Center

Chula Vista, California, United States

Study Center

Fountain Valley, California, United States

Study Center

Fremont, California, United States

Study Center

Los Angeles, California, United States

Study Center

Los Angeles, California, United States

Study Center

San Diego, California, United States

Study Center

Fort Lauderdale, Florida, United States

Study Center

Miramar, Florida, United States

Study Center

Ocala, Florida, United States

Study Center

Tampa, Florida, United States

Study Center

Sandy Springs, Georgia, United States

Study Center

Savannah, Georgia, United States

Study Center

Idaho Falls, Idaho, United States

Study Center

Clarksville, Indiana, United States

Study Center

Louisville, Kentucky, United States

Study Center

Mayfield Heights, Ohio, United States

Study Center

Philadelphia, Pennsylvania, United States

Study Center

San Antonio, Texas, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07489885

Related Trials

Metabolic Profiling of Immune Responses in Immune-mediated Diseases

NCT048648861 location

Skin Microbial Ecology in Atopic Dermatitis

NCT041702441 location

SEquential Treatment of PSoriasis With Biologics

NCT071878171 location

A Study of Persistence to Guselkumab Treatment in Participants With Moderate-to-Severe Plaque Psoriasis in Romania

NCT0758278319 locations

Use of a Digital Psychotherapeutic App to Reduce Symptom Burden in Dermatology Patients

NCT067022931 location